Perimenopausal Depression
7
1
1
4
Key Insights
Highlights
Success Rate
80% trial completion
Clinical Risk Assessment
Based on trial outcomes
Moderate Risk
Score: 39/100
14.3%
1 terminated out of 7 trials
80.0%
-6.5% vs benchmark
43%
3 trials in Phase 3/4
50%
2 of 4 completed with results
Key Signals
Data Visualizations
Phase Distribution
Trial Status
Trial Success Rate
Benchmark: 86.5%
Based on 4 completed trials
Clinical Trials (7)
The Effect of Cold Packs on Hot Flushes and Depression in Women Going Through the Climacteric Period
A Trial to Investigate the Accuracy of a Wearable Device in Collecting Data Related to Perimenopausal Symptoms in Women
Testing the Efficacy of Mindfulness-based Stress Reduction in the Prevention of Perimenopausal Depression
The Effects of Estrogen Withdrawal on Mood Symptoms in Women
Perimenopausal Effects of Estradiol on Reward Responsiveness
Raloxifene and Rimostil for Perimenopause-Related Depression
Investigation of Tibolone and Escitalopram in Perimenopausal Depression